Rifat Pamukcu

Rifat Pamukcu

Director/Board Member at APREA THERAPEUTICS, INC.

Net worth: 16 529 $ as of 2026-05-30

68 year
Health Technology
Consumer Services
Commercial Services

Profile

Rifat Pamukcu is the founder of Cell Pathways, Inc. Current jobs include Chairman, President & Chief Executive Officer at Midway Pharmaceuticals, Inc. since 2005, President & Chief Executive Officer at Atrin Pharmaceuticals LLC, Chief Executive Officer & Director at RxMP Therapeutics, Inc. since 2016, Director at Virion Therapeutics LLC since 2018, Independent Director at Aprea Therapeutics, Inc. since 2022, Director at Syantra, Inc. since 2019, Director at SIRPant Immunotherapeutics, Inc. since 2021, and Managing Partner at Corami LLC since 2016.
Former job includes Director at Atrin Pharmaceuticals, Inc. Education includes an undergraduate degree from The Johns Hopkins University and a doctorate from the University of Wisconsin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-20 18,509 ( 0.15% ) 16 529 $ 2026-05-30

Rifat Pamukcu active positions

CompaniesPositionStart
APREA THERAPEUTICS, INC. Director/Board Member 2022-04-30
Chief Executive Officer 2004-12-31
Chief Executive Officer -
Chief Executive Officer 2015-12-31
Director/Board Member 2017-12-31
Director/Board Member 2020-12-31
Corami LLC
Corporate Officer/Principal 2015-12-31
Director/Board Member 2018-12-31

Former positions of Rifat Pamukcu

CompaniesPositionEnd
Founder 2002-12-31
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Rifat Pamukcu's experience

Training of Rifat Pamukcu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

11

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Corami LLC

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!